Skip to main content
. 2011 Apr 14;17(14):1866–1873. doi: 10.3748/wjg.v17.i14.1866

Table 2.

Correlation between glucose transporter 1 expression and clinicopathologic factors in colorectal adenocarcinomas (n = 515) n (%)

Factors n Expression of GLUT1
< 50% (%) ≥ 50% (%) P value
(n = 328) (n = 187)
Age (yr) 0.0691
< 58 244 164 (67.2) 80 (32.8)
≥ 58 271 164 (60.5) 107 (39.5)
Gender 0.0091
Male 293 200 (68.3) 93 (31.7)
Female 222 128 (57.7) 94 (42.3)
Tumor location 0.5061
Colon 266 169 (63.5) 97 (36.5)
Rectum 249 159 (63.9) 90 (36.1)
Tumor size (cm) 0.5071
< 5.7 282 180 (63.8) 102 (36.2)
≥ 5.7 233 148 (63.5) 85 (36.5)
Tumor gross 0.2161
Fungating 239 157 (65.7) 82 (34.3)
Infiltrative 276 171 (62.0) 105 (38.0)
Tumor type 0.0451
Non-mucinous 489 307 (62.8) 182 (37.2)
Mucinous 26 21 (80.8) 5 (19.2)
Differentiation 0.0012
Well 21 19 (90.5) 2 (9.5)
Moderate 386 252 (65.3) 134 (34.7)
Poor 108 57 (52.8) 51 (47.2)
T category 0.2262
Tis, T1 16 13 (81.3) 3 (18.8)
T2 35 22 (62.9) 13 (37.1)
T3 452 286 (63.3) 166 (36.7)
T4 12 7 (58.3) 5 (41.7)
N category < 0.0012
N0 226 170 (75.2) 56 (24.8)
N1 130 73 (56.2) 57 (43.8)
N2 159 85 (53.5) 74 (46.5)
M category 0.1451
M0 495 318 (64.2) 177 (35.8)
M1 20 10 (50.0) 10 (50.0)
AJCC stage < 0.0012
0, I 41 30 (73.2) 11 (26.8)
IIA, IIB 183 139 (76.0) 44 (24.0)
IIIA, IIIB, IIIC 271 149 (55.0) 122 (45.0)
IV 20 10 (50.0) 10 (50.0)
Dukes stage < 0.0012
A 12 10 (83.3) 2 (16.7)
B1, B2 208 156 (75.0) 52 (25.0)
C1, C2 275 152 (55.3) 123 (44.7)
D 20 10 (50.0) 10 (50.0)
Apaf-1 0.001
Negative 401 241 (60.1) 160 (39.9)
Positive 114 87 (76.3) 27 (23.7)
1

Fisher’s exact test,

2

: χ2 test for linear trend. GLUT1: Glucose transporter 1; Apaf-1: Apoptosis-activating factor-1.